Skip to main content
Publish date:

ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition Of Flexion Therapeutics, Inc.

NEW YORK, Oct. 11, 2021 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Flexion Therapeutics, Inc.

NEW YORK, Oct. 11, 2021 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Flexion Therapeutics, Inc. (FLXN) - Get Flexion Therapeutics, Inc. Report and its board of directors concerning the proposed acquisition of the company by Pacira BioSciences, Inc. (PCRX) - Get Pacira Biosciences, Inc. Report. Stockholders will receive $8.50 and one contingent value right worth up to $8.00 for each share of Flexion Therapeutics stock that they hold. The transaction is expected to close in the fourth quarter of 2021.

If you are a stockholder of Flexion Therapeutics, Inc. and are interested in obtaining additional information regarding this investigation, please visit us at:  http://www.rowleylawpllc.com/investigation/flxn/. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at info@rowleylawpllc.com , or by telephone at 914-400-1920 or 844-400-4643 (toll-free).  

Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com

Attorney Advertising. Prior results do not guarantee a similar outcome.

View original content: https://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-flexion-therapeutics-inc-301397278.html

SOURCE Rowley Law PLLC